Riluzole: Clinical Trials

6 trials of Riluzole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 5, Terminated 1

Follow Riluzole: new trials by email Literature Review of Riluzole trials Research Report on Riluzole

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
Riluzole, Placebo - Inflammation, Fatigue
Phase 4CompletedEmory University302016-04-012021-04-14
Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission
D-serine, Riluzole, Placebo - Tourette Syndrome
Phase 4CompletedJohns Hopkins University392009-11-012018-01-30
Riluzole in Fragile X Syndrome
Riluzole - Fragile X Syndrome
Phase 4CompletedIndiana University62009-04-012017-04-18
Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
Lamotrigine, Ketamine, Riluzole - Major Depression
Phase 4CompletedBaylor College of Medicine262006-12-012019-07-31
Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes
Memantine, Riluzole - Mood, Memory Deficit
Phase 4TerminatedUniversity of Texas Southwestern Medical Center202005-11-012013-04-23
CARE Canadian ALS Riluzole Evaluation
Riluzole - Amyotrophic Lateral Sclerosis
Phase 4CompletedSanofi4142001-01-012007-10-11

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  Behavior (1)  ·  Cognitive Dysfunction (1)  ·  Depressive Disorder, Major (1)  ·  Fatigue (1)  ·  Fragile X Syndrome (1)  ·  Inflammation (1)  ·  Memory Disorders (1)  ·  Tics (1)  ·  Tourette Syndrome (1)

Sponsors

Baylor College of Medicine (1)  ·  Emory University (1)  ·  Indiana University (1)  ·  Johns Hopkins University (1)  ·  Sanofi (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (5)  ·  Canada (1)

Top investigators

Andrew H Miller, MD (1)  ·  Craig A. Erickson, MD (1)  ·  Harvey S Singer, MD (1)  ·  Laurent-Didier Jacobs (1)  ·  Sanjay Mathew, MD (1)  ·  Sherwood Brown (1)

Results publications

PMID 19288975, PMID 19545857, PMID 21059347, PMID 25271445

NIH funding

M01RR000071 (1), R34MH085844 (1)